Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 945

1.

Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC Trial.

Cooper CM, Chin Fatt CR, Jha M, Fonzo GA, Grannemann BD, Carmody T, Ali A, Aslan S, Almeida JRC, Deckersbach T, Fava M, Kurian BT, McGrath PJ, McInnis M, Parsey RV, Weissman M, Phillips ML, Lu H, Etkin A, Trivedi MH.

EClinicalMedicine. 2019 May 18;10:32-41. doi: 10.1016/j.eclinm.2019.04.007. eCollection 2019 Apr.

PMID:
31193824
2.

Mandibular radiomorphometric assessment of bone mineral density in survivors of pediatric hematopoietic stem-cell transplantation.

Frascino AV, Costa C, Salgado DMRA, Coracin FL, Fava M, Odone-Filho V.

Clinics (Sao Paulo). 2019;74:e929. doi: 10.6061/clinics/2019/e929. Epub 2019 May 30.

3.

Examining raphe-amygdala structural connectivity as a biological predictor of SSRI response.

Pillai RLI, Huang C, LaBella A, Zhang M, Yang J, Trivedi M, Weissman M, McGrath P, Fava M, Kurian B, Cooper C, McInnis M, Oquendo MA, Pizzagalli DA, Parsey RV, DeLorenzo C.

J Affect Disord. 2019 May 28;256:8-16. doi: 10.1016/j.jad.2019.05.055. [Epub ahead of print]

PMID:
31158720
4.
5.

Deformities of the Globus Pallidus are Associated with Severity of Suicidal Ideation and Impulsivity in Patients with Major Depressive Disorder.

Kim K, Shin JH, Myung W, Fava M, Mischoulon D, Papakostas GI, Choi KW, Na EJ, Seo SW, Seong JK, Jeon HJ.

Sci Rep. 2019 May 16;9(1):7462. doi: 10.1038/s41598-019-43882-4.

6.

Risks of Completed Suicide of Community Individuals with ICD-10 Disorders Across Age Groups: A Nationwide Population-Based Nested Case-Control Study in South Korea.

Na EJ, Lee H, Myung W, Fava M, Mischoulon D, Paik JW, Hong JP, Choi KW, Kim H, Jeon HJ.

Psychiatry Investig. 2019 Apr;16(4):314-324. doi: 10.30773/pi.2019.02.19. Epub 2019 Apr 24.

7.

Childhood trauma history is linked to abnormal brain connectivity in major depression.

Yu M, Linn KA, Shinohara RT, Oathes DJ, Cook PA, Duprat R, Moore TM, Oquendo MA, Phillips ML, McInnis M, Fava M, Trivedi MH, McGrath P, Parsey R, Weissman MM, Sheline YI.

Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8582-8590. doi: 10.1073/pnas.1900801116. Epub 2019 Apr 8.

8.

Efficacy and Tolerability of Adjunctive Intravenous Sodium Nitroprusside Treatment for Outpatients With Schizophrenia: A Randomized Clinical Trial.

Brown HE, Freudenreich O, Fan X, Heard SO, Goff D, Petrides G, Harrington AL, Kane JM, Judge H, Hoeppner B, Fava M, Perlis RH.

JAMA Psychiatry. 2019 Mar 27. doi: 10.1001/jamapsychiatry.2019.0151. [Epub ahead of print]

PMID:
30916714
9.

50 Adjunctive Buprenorphine/Samidorphan Combination in Patients with Major Depressive Disorder: Phase 3 Long-term Extension Study Results.

Thase M, Stanford AD, Memisoglu A, Martin W, Claxton A, Bodnik JA, Trivedi MH, Fava M, Pathak S.

CNS Spectr. 2019 Feb;24(1):203-204. doi: 10.1017/S1092852919000427.

PMID:
30859977
10.

Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept study.

Biederman J, Lindsten A, Sluth LB, Petersen ML, Ettrup A, Eriksen HF, Fava M.

J Psychopharmacol. 2019 Apr;33(4):511-521. doi: 10.1177/0269881119832538. Epub 2019 Mar 7.

PMID:
30843450
11.

Locally different proteome in aortas from patients with stenotic tricuspid and bicuspid aortic valves†.

Forte A, Yin X, Fava M, Bancone C, Cipollaro M, De Feo M, Mayr M, Jahangiri M, Della Corte A.

Eur J Cardiothorac Surg. 2019 Feb 25. pii: ezz032. doi: 10.1093/ejcts/ezz032. [Epub ahead of print]

PMID:
30805593
12.

A commentary on: statistical inference problems in sequential parallel comparison designs.

Schoenfeld DA, Doros G, Fava M.

J Biopharm Stat. 2019 Feb 22:1-4. doi: 10.1080/10543406.2019.1584207. [Epub ahead of print]

PMID:
30794042
13.

Increased amygdala-visual cortex connectivity in youth with persecutory ideation.

DeCross SN, Farabaugh AH, Holmes AJ, Ward M, Boeke EA, Wolthusen RPF, Coombs G, Nyer M, Fava M, Buckner RL, Holt DJ.

Psychol Med. 2019 Feb 12:1-11. doi: 10.1017/S0033291718004221. [Epub ahead of print]

PMID:
30744715
14.

Pretreatment Rostral Anterior Cingulate Cortex Connectivity With Salience Network Predicts Depression Recovery: Findings From the EMBARC Randomized Clinical Trial.

Whitton AE, Webb CA, Dillon DG, Kayser J, Rutherford A, Goer F, Fava M, McGrath P, Weissman M, Parsey R, Adams P, Trombello JM, Cooper C, Deldin P, Oquendo MA, McInnis MG, Carmody T, Bruder G, Trivedi MH, Pizzagalli DA.

Biol Psychiatry. 2019 May 15;85(10):872-880. doi: 10.1016/j.biopsych.2018.12.007. Epub 2018 Dec 19.

PMID:
30718038
15.

Comparison of suicide attempts in individuals with major depressive disorder with and without history of subthreshold hypomania: A nationwide community sample of Korean adults,✰✰.

Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ.

J Affect Disord. 2019 Apr 1;248:18-25. doi: 10.1016/j.jad.2019.01.022. Epub 2019 Jan 26.

PMID:
30710859
16.

Anxiety and anhedonia in depression: Associations with neuroticism and cognitive control.

Liao A, Walker R, Carmody TJ, Cooper C, Shaw MA, Grannemann BD, Adams P, Bruder GE, McInnis MG, Webb CA, Dillon DG, Pizzagalli DA, Phillips ML, Kurian BT, Fava M, Parsey RV, McGrath PJ, Weissman MM, Trivedi MH.

J Affect Disord. 2019 Feb 15;245:1070-1078. doi: 10.1016/j.jad.2018.11.072. Epub 2018 Nov 14.

PMID:
30699849
17.

Multiple types of somatic pain increase suicide attempts and depression: A nationwide community sample of Korean adults.

Park MJ, Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, Mischoulon D, Jeon HJ.

Compr Psychiatry. 2019 Apr;90:43-48. doi: 10.1016/j.comppsych.2018.12.006. Epub 2018 Dec 19.

18.

Sex differences in response to ketamine as a rapidly acting intervention for treatment resistant depression.

Freeman MP, Papakostas GI, Hoeppner B, Mazzone E, Judge H, Cusin C, Mathew S, Sanacora G, Iosifescu D, DeBattista C, Trivedi MH, Fava M.

J Psychiatr Res. 2019 Mar;110:166-171. doi: 10.1016/j.jpsychires.2019.01.010. Epub 2019 Jan 8.

PMID:
30641350
19.

A phase 2, double-blind, placebo-controlled study of NSI-189 phosphate, a neurogenic compound, among outpatients with major depressive disorder.

Papakostas GI, Johe K, Hand H, Drouillard A, Russo P, Kay G, Kashambwa R, Hoeppner B, Flynn M, Yeung A, Martinson MA, Fava M.

Mol Psychiatry. 2019 Jan 9. doi: 10.1038/s41380-018-0334-8. [Epub ahead of print]

PMID:
30626911
20.

Correction: Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI.

Mol Psychiatry. 2019 Jan 7. doi: 10.1038/s41380-018-0311-2. [Epub ahead of print]

PMID:
30617276
21.

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.

Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI.

Depress Anxiety. 2019 Mar;36(3):235-243. doi: 10.1002/da.22875. Epub 2018 Dec 30.

PMID:
30597688
22.

Heart rate variability for treatment response between patients with major depressive disorder versus panic disorder: A 12-week follow-up study.

Choi KW, Jang EH, Kim AY, Fava M, Mischoulon D, Papakostas GI, Kim DJ, Kim K, Yu HY, Jeon HJ.

J Affect Disord. 2019 Mar 1;246:157-165. doi: 10.1016/j.jad.2018.12.048. Epub 2018 Dec 18.

PMID:
30583140
23.

Review of a three-year study on the dental care of onco-hematological pediatric patients.

Frascino AV, Fava M, Cominato L, Odone-Filho V.

Clinics (Sao Paulo). 2018 Dec 3;73:e721. doi: 10.6061/clinics/2017/e721. Review.

24.

Tachyphylaxis in major depressive disorder: A review of the current state of research.

Kinrys G, Gold AK, Pisano VD, Freeman MP, Papakostas GI, Mischoulon D, Nierenberg AA, Fava M.

J Affect Disord. 2019 Feb 15;245:488-497. doi: 10.1016/j.jad.2018.10.357. Epub 2018 Oct 28. Review.

PMID:
30439676
25.

Can electronic health records revive central nervous system clinical trials?

Perlis RH, Fava M, McCoy TH Jr.

Mol Psychiatry. 2018 Nov 14. doi: 10.1038/s41380-018-0278-z. [Epub ahead of print] No abstract available.

PMID:
30429581
26.

Understanding the effects of emotional reactivity on depression and suicidal thoughts and behaviors: Moderating effects of childhood adversity and resilience.

Shapero BG, Farabaugh A, Terechina O, DeCross S, Cheung JC, Fava M, Holt DJ.

J Affect Disord. 2019 Feb 15;245:419-427. doi: 10.1016/j.jad.2018.11.033. Epub 2018 Nov 5.

PMID:
30423470
27.

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies.

Fava M, Thase ME, Trivedi MH, Ehrich E, Martin WF, Memisoglu A, Nangia N, Stanford AD, Yu M, Pathak S.

Mol Psychiatry. 2018 Oct 29. doi: 10.1038/s41380-018-0284-1. [Epub ahead of print] No abstract available.

PMID:
30374191
28.

Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial.

Quinn GR, Hellkamp AS, Hankey GJ, Becker RC, Berkowitz SD, Breithardt G, Fava M, Fox KAA, Halperin JL, Mahaffey KW, Nessel CC, Patel MR, Piccini JP, Singer DE.

J Am Heart Assoc. 2018 Aug 7;7(15):e008755. doi: 10.1161/JAHA.118.008755.

29.

Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial.

Cassano P, Petrie SR, Mischoulon D, Cusin C, Katnani H, Yeung A, De Taboada L, Archibald A, Bui E, Baer L, Chang T, Chen J, Pedrelli P, Fisher L, Farabaugh A, Hamblin MR, Alpert JE, Fava M, Iosifescu DV.

Photomed Laser Surg. 2018 Oct 20. doi: 10.1089/pho.2018.4490. [Epub ahead of print]

PMID:
30346890
30.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

Ionescu DF, Bentley KH, Eikermann M, Taylor N, Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C.

J Affect Disord. 2019 Jan 15;243:516-524. doi: 10.1016/j.jad.2018.09.037. Epub 2018 Sep 17.

PMID:
30286416
31.

Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD).

Fava M, Freeman MP, Flynn M, Judge H, Hoeppner BB, Cusin C, Ionescu DF, Mathew SJ, Chang LC, Iosifescu DV, Murrough J, Debattista C, Schatzberg AF, Trivedi MH, Jha MK, Sanacora G, Wilkinson ST, Papakostas GI.

Mol Psychiatry. 2018 Oct 3. doi: 10.1038/s41380-018-0256-5. [Epub ahead of print] Erratum in: Mol Psychiatry. 2019 Jan 7;:.

32.

Anxiety attacks with or without life-threatening situations, major depressive disorder, and suicide attempt: a nationwide community sample of Korean adults.

Kim H, Choi KW, Na EJ, Hong JP, Fava M, Mischoulon D, Cho H, Jeon HJ.

Psychiatry Res. 2018 Dec;270:257-263. doi: 10.1016/j.psychres.2018.09.050. Epub 2018 Sep 21.

PMID:
30273856
33.

Increased adrenocorticotropic hormone (ACTH) levels predict severity of depression after six months of follow-up in outpatients with major depressive disorder.

Choi KW, Na EJ, Fava M, Mischoulon D, Cho H, Jeon HJ.

Psychiatry Res. 2018 Dec;270:246-252. doi: 10.1016/j.psychres.2018.09.047. Epub 2018 Sep 21.

PMID:
30269042
34.

Mechanisms of Perceived Treatment Assignment and Subsequent Expectancy Effects in a Double Blind Placebo Controlled RCT of Major Depression.

Laferton JAC, Vijapura S, Baer L, Clain AJ, Cooper A, Papakostas G, Price LH, Carpenter LL, Tyrka AR, Fava M, Mischoulon D.

Front Psychiatry. 2018 Sep 7;9:424. doi: 10.3389/fpsyt.2018.00424. eCollection 2018.

35.

Effects of transcranial photobiomodulation with near-infrared light on sexual dysfunction.

Cassano P, Dording C, Thomas G, Foster S, Yeung A, Uchida M, Hamblin MR, Bui E, Fava M, Mischoulon D, Iosifescu DV.

Lasers Surg Med. 2019 Feb;51(2):127-135. doi: 10.1002/lsm.23011. Epub 2018 Sep 17.

PMID:
30221776
36.

Risk Factors for Depression in Adolescents With ADHD: The Impact of Cognitive Biases and Stress.

Shapero BG, Gibb BE, Archibald A, Wilens TE, Fava M, Hirshfeld-Becker DR.

J Atten Disord. 2018 Sep 10:1087054718797447. doi: 10.1177/1087054718797447. [Epub ahead of print]

PMID:
30198368
37.

Resting EEG Measures of Brain Arousal in a Multisite Study of Major Depression.

Ulke C, Tenke CE, Kayser J, Sander C, Böttger D, Wong LYX, Alvarenga JE, Fava M, McGrath PJ, Deldin PJ, Mcinnis MG, Trivedi MH, Weissman MM, Pizzagalli DA, Hegerl U, Bruder GE.

Clin EEG Neurosci. 2019 Jan;50(1):3-12. doi: 10.1177/1550059418795578. Epub 2018 Sep 5.

PMID:
30182751
38.

Development and evaluation of a multimodal marker of major depressive disorder.

Yang J, Zhang M, Ahn H, Zhang Q, Jin TB, Li I, Nemesure M, Joshi N, Jiang H, Miller JM, Ogden RT, Petkova E, Milak MS, Sublette ME, Sullivan GM, Trivedi MH, Weissman M, McGrath PJ, Fava M, Kurian BT, Pizzagalli DA, Cooper CM, McInnis M, Oquendo MA, Mann JJ, Parsey RV, DeLorenzo C.

Hum Brain Mapp. 2018 Nov;39(11):4420-4439. doi: 10.1002/hbm.24282. Epub 2018 Aug 16.

PMID:
30113112
39.

A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.

Trivedi MH, South C, Jha MK, Rush AJ, Cao J, Kurian B, Phillips M, Pizzagalli DA, Trombello JM, Oquendo MA, Cooper C, Dillon DG, Webb C, Grannemann BD, Bruder G, McGrath PJ, Parsey R, Weissman M, Fava M.

Psychother Psychosom. 2018;87(5):285-295. doi: 10.1159/000491093. Epub 2018 Aug 15.

PMID:
30110685
40.

Efficacy of adjunctive low-dose cariprazine in major depressive disorder: a randomized, double-blind, placebo-controlled trial.

Fava M, Durgam S, Earley W, Lu K, Hayes R, Laszlovszky I, Németh G.

Int Clin Psychopharmacol. 2018 Nov;33(6):312-321. doi: 10.1097/YIC.0000000000000235.

41.

What is the overlap between subjective and objective cognitive impairments in MDD?

Fava M, Mahableshwarkar AR, Jacobson W, Zhong W, Keefe RS, Olsen CK, Jaeger J.

Ann Clin Psychiatry. 2018 Aug;30(3):176-184.

PMID:
30028891
42.

Personalized prediction of antidepressant v. placebo response: evidence from the EMBARC study.

Webb CA, Trivedi MH, Cohen ZD, Dillon DG, Fournier JC, Goer F, Fava M, McGrath PJ, Weissman M, Parsey R, Adams P, Trombello JM, Cooper C, Deldin P, Oquendo MA, McInnis MG, Huys Q, Bruder G, Kurian BT, Jha M, DeRubeis RJ, Pizzagalli DA.

Psychol Med. 2019 May;49(7):1118-1127. doi: 10.1017/S0033291718001708. Epub 2018 Jul 2.

PMID:
29962359
43.

Statistical harmonization corrects site effects in functional connectivity measurements from multi-site fMRI data.

Yu M, Linn KA, Cook PA, Phillips ML, McInnis M, Fava M, Trivedi MH, Weissman MM, Shinohara RT, Sheline YI.

Hum Brain Mapp. 2018 Nov;39(11):4213-4227. doi: 10.1002/hbm.24241. Epub 2018 Jul 1.

PMID:
29962049
44.

Pretreatment and early-treatment cortical thickness is associated with SSRI treatment response in major depressive disorder.

Bartlett EA, DeLorenzo C, Sharma P, Yang J, Zhang M, Petkova E, Weissman M, McGrath PJ, Fava M, Ogden RT, Kurian BT, Malchow A, Cooper CM, Trombello JM, McInnis M, Adams P, Oquendo MA, Pizzagalli DA, Trivedi M, Parsey RV.

Neuropsychopharmacology. 2018 Oct;43(11):2221-2230. doi: 10.1038/s41386-018-0122-9. Epub 2018 Jun 19.

PMID:
29955151
45.

Sex Differences in the Association between Heavy Drinking and Behavioral Distress Tolerance and Emotional Reactivity Among Non-Depressed College Students.

Pedrelli P, MacPherson L, Khan AJ, Shapero BG, Fisher LB, Nyer M, Cassano P, Parnarouskis L, Farabaugh A, Fava M, Silveri MM.

Alcohol Alcohol. 2018 Nov 1;53(6):674-681. doi: 10.1093/alcalc/agy045.

PMID:
29947730
46.

Binge eating, trauma, and suicide attempt in community adults with major depressive disorder.

Baek JH, Kim K, Hong JP, Cho MJ, Fava M, Mischoulon D, Chang SM, Kim JY, Cho H, Jeon HJ.

PLoS One. 2018 Jun 21;13(6):e0198192. doi: 10.1371/journal.pone.0198192. eCollection 2018.

47.

Phase IIb Trial of an α7 Nicotinic Receptor Partial Agonist With and Without Nicotine Patch for Withdrawal-Associated Cognitive Deficits and Tobacco Abstinence.

Schuster RM, Pachas GN, Stoeckel L, Cather C, Nadal M, Mischoulon D, Schoenfeld DA, Zhang H, Ulysse C, Dodds EB, Sobolewski S, Hudziak V, Hanly A, Fava M, Evins AE.

J Clin Psychopharmacol. 2018 Aug;38(4):307-316. doi: 10.1097/JCP.0000000000000919.

PMID:
29912798
48.

Tocolysis among Women with Preterm Birth: Associated Factors and Outcomes from a Multicenter Study in Brazil.

Dias TZ, Fava ML, Passini Júnior R, Cecatti JG, Tedesco RP, Lajos GJ, Rehder PM, Nomura ML, Oliveira PF, Costa ML.

Rev Bras Ginecol Obstet. 2018 Apr;40(4):171-179. doi: 10.1055/s-0038-1642025. Epub 2018 May 10.

49.

Patient primary language in a culturally focused intervention for Latino Americans with depression.

Curren L, Huz I, McKee M, Traeger L, Bedoya CA, Chang TE, Cassano P, Fava M, Alpert J, Yeung A, Gilman SE, Trinh NH.

Ann Clin Psychiatry. 2018 May;30(2):84-90.

50.

Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study.

Trombello JM, Pizzagalli DA, Weissman MM, Grannemann BD, Cooper CM, Greer TL, Malchow AL, Jha MK, Carmody TJ, Kurian BT, Webb CA, Dillon DG, McGrath PJ, Bruder G, Fava M, Parsey RV, McInnis MG, Adams P, Trivedi MH.

J Psychiatr Res. 2018 Jul;102:207-215. doi: 10.1016/j.jpsychires.2018.04.003. Epub 2018 Apr 6.

PMID:
29689518

Supplemental Content

Support Center